Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial (Q35128552)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
scientific article

    Statements

    Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial (English)
    Alan S Maisel
    Christian Mueller
    Robert Fitzgerald
    Robert Brikhan
    Brian C Hiestand
    Navaid Iqbal
    Paul Clopton

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit